NCT00716586View on ClinicalTrials.gov

Treatment of Cystoid Macular Edema in Patients With Retinal Degeneration

PHASE4CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

August 11, 2015

Study Completion Date

November 17, 2017

Conditions
Retinal Degenerations
Interventions
DRUG

2% dorzolamide

Carbonic anhydrase inhibitor, Trusopt (2% dorzolamide)

Trial Locations (1)

60612

University of Illinois Medical Center, Chicago

All Listed Sponsors
lead

University of Illinois at Chicago

OTHER

NCT00716586 - Treatment of Cystoid Macular Edema in Patients With Retinal Degeneration | Biotech Hunter | Biotech Hunter